Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
166.26B
Market cap166.26B
Price-Earnings ratio
25.67
Price-Earnings ratio25.67
Dividend yield
2.51%
Dividend yield2.51%
Average volume
11.68M
Average volume11.68M
High today
$96.05
High today$96.05
Low today
$95.54
Low today$95.54
Open price
$97.13
Open price$97.13
Volume
61.74K
Volume61.74K
52 Week high
$139.06
52 Week high$139.06
52 Week low
$93.92
52 Week low$93.92

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $95.70. The company's market cap stands at 166.26B, with a P/E ratio of 25.67 and a dividend yield of 2.5%.

On 2026-04-17, Abbott(ABT) stock moved within a range of $95.54 to $96.05. With shares now at $95.70, the stock is trading +0.2% above its intraday low and -0.4% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 61.74K, versus its average volume of 11.68M.

The stock's 52-week range extends from a low of $93.92 to a high of $139.06.

The stock's 52-week range extends from a low of $93.92 to a high of $139.06.

ABT News

TipRanks 2h
Abbott price target lowered to $115 from $135 at Piper Sandler

Piper Sandler lowered the firm’s price target on Abbott (ABT) to $115 from $135 and keeps an Overweight rating on the shares. The firm notes the company reporte...

Benzinga 12h
Netflix, AMD, Navitas Semiconductor, Abbott Labs, And Nio: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average up 0.2% at 48,578.72, the S&P 500 gaining nearly 0.3% to 7,041.28, and the N...

Netflix, AMD, Navitas Semiconductor, Abbott Labs, And Nio: Why These 5 Stocks Are On Investors' Radars Today
TipRanks 13h
Abbott Laboratories Bets on Devices in 2026 Call

Abbott Laboratories ((ABT)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Unlock hedge fund-level data and...

Analyst ratings

78%

of 32 ratings
Buy
78.1%
Hold
21.9%
Sell
0%

More ABT News

Nasdaq 14h
Why Abbott Laboratories Stock Tumbled on Thursday

Key Points Investors had more of an issue with guidance. The company cut its full-year forecast for adjusted profitability. 10 stocks we like better than Abb...

Why Abbott Laboratories Stock Tumbled on Thursday
Simply Wall St 16h
Is Abbott Laboratories Now Offering Value After A 20% Share Price Slide?

If you are wondering whether Abbott Laboratories at around US$101.56 is offering value or just noise, it helps to step back and look at the full picture on pric...

Is Abbott Laboratories Now Offering Value After A 20% Share Price Slide?
The Wall Street Journal 18h
Abbott Stock Falls After Results Show Pressure in Several Businesses

Abbott Laboratories shares are down about 6% after the medical devices and nutrition company gave a 2026 forecast that disappointed analysts. In its first quar...

Abbott Stock Falls After Results Show Pressure in Several Businesses
Benzinga 21h
Abbott Labs Annual Guidance Cut Overshadows Earnings Beat, Stock Cracks

Earnings Beat Fails To Offset Weak 2026 Outlook The global healthcare company reported quarterly sales of $11.16 billion, slightly beating the consensus of $10....

Abbott Labs Annual Guidance Cut Overshadows Earnings Beat, Stock Cracks
Seeking Alpha 21h
Health Care ETFs take notice as Abbott Laboratories slides on earnings

Abbott Laboratories (ABT) and exchange traded funds with significant exposure to the healthcare company drew investor attention Thursday after the stock decline...

Health Care ETFs take notice as Abbott Laboratories slides on earnings
The Wall Street Journal 22h
Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Abbott Laboratories attributed the lower outlook to its acquisition of cancer-diagnostics company Exact Sciences. Maxim Shemetov/Reuters Abbott Laboratories AB...

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales
Nasdaq 23h
Abbott Q1 2026 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Abbott Q1 2026 Earnings Call Transcript

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.